Transasia Bio-Medicals Ltd., India’s largest IVD Company Acquires Maxmat S. A., France.

Oct. 16, 2012 - PRLog -- Transasia Bio-Medicals Ltd., (Transasia) - India’s largest IVD company and recipient of various prestigious national and state level awards, announces its acquisition of Maxmat S.A based at Montpellier, France - a company specializing in conception, design, development and manufacturing of automated analyzers and reagents in the field of Clinical Chemistry, Hemostasis and Immunology, through its Czech subsidiary Erba Lachema.
Incepted in the year 1979, Transasia Bio-Medicals Ltd., is headquartered in Mumbai, India. It is one of India’s largest In Vitro Diagnostics Company offering solutions and products in Biochemistry, Hematology, Coagulation, ESR, Immunology, Urinalysis, Critical Care, Electrophoresis, Molecular Diagnostics, Diabetes Management and Microbiology.
Maxmat S. A, will be eventually rechristened as Erba Diagnostics France S.A.R.L.. Erba Diagnostics France will benefit the entire Group with its capabilities and know how in the field of design and development of analyzers which perform multiple functions in a laboratory spanning different segments of biochemistry, hemostasis and immunology. Amongst its product-line is a revolutionary multi-analyzer that can conduct hundreds of different biochemistry, coagulation and immunology tests on a sample.
This would be the fourth acquisition made by Transasia Bio-Medicals Ltd. in the last three years. Earlier acquisitions have been made in USA, Italy, Czech and Turkey. Erba has acquired the entire business assets of the company along with plant and intellectual assets of the company in the form of patents and other proprietary know how. Erba has also decided to retain the entire management team.
The acquisition will help in shrinking development timelines, for new advanced technologies and to fulfill the needs of diagnostic laboratories worldwide. Erba Diagnostics, France (formerly Maxmat S.A) will also improve the Group’s presence in the French market and French speaking North African countries.
Mr. Suresh Vazirani, Chairman and Managing Director, Transasia Bio-Medicals Ltd., stated that “We are excited about the new opportunities that are offered by this strategic acquisition. This acquisition will strengthen the Group’s plans to emerge as a global leader in IVD.”
Furthermore, Erba Group and Erba Diagnostics France (formerly Maxmat S.A) have drawn up growth plans based on achieving economies of scale, creating synergy through intra-Group co-ordination, widening product offering and strengthening its after sales service support and distribution network.
Transasia - Erba continues in its mission to help doctors and patients worldwide, in meeting their needs for reliable, affordable and innovative medical diagnostic systems
About Transasia Bio-Medicals Ltd
Incepted in the year 1979, Transasia Bio-Medicals Ltd., is headquartered in Mumbai, India. It is one of India’s largest In Vitro Diagnostics Company and offers solutions and products in Biochemistry, Hematology, Coagulation, ESR, Immunology, Urinalysis, Critical Care, Electrophoresis, Molecular Diagnostics, Diabetes Management and Microbiology. Transasia is a part of the global Erba Mannheim GmbH Group.
The Erba Diagnostics Group has spread its footprint across USA, Europe, Turkey and Eastern Europe &Russia, by means of various acquisitions – ErbaLachema s.r.o., Lachema International, IVAX Diagnostics, Inc., Diamedix Biologicals, S.r.l., ImmunoVision, Inc. and Erba Diasis Diagnostik Sistemler. Transasia manufactures and markets equipments and reagents, with an impressive install base of around 30,000 equipments across India. Transasia also exports to more than 60 countries worldwide. The vast network of more than 150 service engineers, 300 + Sales and Marketing Team, 14 zonal offices, and 300 + Distributors allows us to reach out to customers across the length and breadth of the country.  Alliances with international partners like Sysmex Corporation Japan, Wako Japan, Medica USA, Diesse Italy, IMMCO USA, Vircell Spain, Helena Biosciences UK, Genprobe USA, have ensured that cutting edge technology and solutions can be brought to India. (www.transasia.co.in )